Brazil to shake-up device, drug clinical trial approval process
This article was originally published in Clinica
Executive Summary
The Brazilian regulatory agency, Anvisa, has drawn up proposals for streamlining and accelerating the approval processes for applications to conduct clinical trials of new medical devices and drugs. The proposals are open for public consultation until 11 September.